Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

  • Biotechnology
  • Chemicals
  • Food processing
  • Electronics
  • Healthcare
  • Pharmaceuticals


Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

  • Market segmentation
  • Competitive landscape
  • Regulatory policies
  • Latest technology trends
  • Acquisition evaluations
  • Vendors’ analysis, etc.
Publications found: 60,074
Sort by:

2017 Iceland Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Ireland Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Latvia Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Lithuania Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Malta Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Netherlands Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Norway Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Poland Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Portugal Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Romania Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Slovakia Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Slovenia Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Sweden Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Switzerland Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

US$ 3,375.00

... current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report provides specimen, test volume and sales forecasts; compares ...

March 2017 517 pages

2017 Germany Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 3,915.00

... infectious diseases by market segment. Five-year test volume and sales projections. Market Segmentation Analysis Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays ...

March 2017 615 pages

2017 Italy Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 3,915.00

... infectious diseases by market segment. Five-year test volume and sales projections. Market Segmentation Analysis Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays ...

March 2017 610 pages

2017 Japan Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 4,860.00

... five years. Japan Market Overview Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment ... of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular ...

March 2017 620 pages

2017 Spain Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 3,915.00

... five years. Spain Market Overview Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment ... of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular ...

March 2017 610 pages

2017 UK Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 3,915.00

... infectious diseases by market segment. Five-year test volume and sales projections. Market Segmentation Analysis Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays ...

March 2017 615 pages

2017 US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 5,580.00

... infectious diseases by market segment. Five-year test volume and sales projections. Market Segmentation Analysis Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays ...

March 2017 636 pages

2017 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 22,050.00

... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

March 2017 1200 pages

2017 Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

US$ 22,050.00

... Antidepressants. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and ... market applications. Comprehensive lists of companies developing or marketing new technologies and products by test. Worldwide Market Overview Estimates of facilities performing clinical chemistry and immunodiagnostic ...

March 2017 1115 pages

2017 Paint, Coatings, Adhesives, Finishes: Tectonic Shifts Demand New Business Models and Partnership Ventures

US$ 3,465.00

... paint and coatings market, as well assupplier strategies, marketing tactics, and technological know-how.The report presents a worldwide strategic overview of the paint and coatings ...

March 2017 142 pages

2017 Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

US$ 22,050.00

... , Italy, Japan, Spain, UK, USA Worldwide Market Overview Facilities performing hematology and flow cytometry testing by country. Test volume and sales projections by country ... study reviews current instrumentation technologies , and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. The report features ...

March 2017 700 pages

2017 Orthopedics: Accelerated Rate of Change and Regulatory Uncertainty Confronting the Industry--Performance, Capabilities, Goals and Strategies of Leading Orthopedics Companies

US$ 3,465.00

This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments ... major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation ...

March 2017 325 pages

2017 Diagnostic Imaging: A Market in Transition Amid Regulatory Uncertainty and Intensifying Competition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS

US$ 3,465.00

This new worldwide strategic overview of the diagnostic imaging market includes the following: Estimates of the market size and growth. Sales forecasts by geographic region ... ; System service and support.• Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine ...

March 2017 185 pages

2017 Flavors, Fragrances, Aroma Chemicals, Essential Oils: Formula for Success--Superior Customer Insights and Exclusive Manufacturing Know-How to Support Customer Demands

US$ 3,465.00

... overview of the flavor and fragrance markets includes: Review of major geographic regions (USA, Europe, Asia). Analysis of key product categories (flavors, fragrances, aroma chemicals, essential oils ... fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others. Know-how in chemical ...

March 2017 154 pages

2017 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 1,665.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... tasks for diagnostic companies during the next five years. Germany Market Overview Laboratories performing DNA sequencing and molecular ...

March 2017 407 pages

2017 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 1,665.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... tasks for diagnostic companies during the next five years. Italy Market Overview Laboratories performing DNA sequencing and molecular ...

March 2017 402 pages

2017 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 2,205.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... tasks for diagnostic companies during the next five years. Japan Market Overview Laboratories performing DNA sequencing and molecular ...

March 2017 410 pages

2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 1,665.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well a forensic and paternity/HLA typing applications during the ... tasks for diagnostic companies during the next five years. Spain Market Overview Laboratories performing DNA sequencing and molecular ...

March 2017 407 pages

2017 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 1,665.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...

March 2017 408 pages

2017 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 2,475.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...

March 2017 430 pages

2017 Nucleic Acid Testing: Infectious Diseases, Cancer, Genetic Diseases, Forensic Testing, Paternity Testing/HLA Typing--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 22,050.00

... test volume and sales forecasts for majorapplications, including:- Infectious Diseases- Forensic Testing- Cancer- Paternity Testing/HLA Typing- Genetic Diseases- Others- Ten-year test ... and other suppliers.- Extensive review of NAT technologies,test formats, detection methodologies, trendsin testing automation and over 30 target/signalamplification methods, including ...

March 2017 1050 pages

2017 Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 22,050.00

... molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies ...

March 2017 1050 pages

2017 France Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape

US$ 3,915.00

... five years. France Market Overview Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment ... of infectious disease molecular diagnostic reagent kits and components. Five-year test volume and sales projections for over 40 infectious disease molecular ...

March 2017 615 pages

2017 Synthes: Strategies, Marketing, R&D, Technologies, Products, Organization

US$ 1,665.00

... strategic assessment of Synthes, one of the worlds leading orthopedics companies, provides significant competitor ... of effective marketing and R&D programs. The report presents a comprehensive analysis of the companys performance, capabilities, goals and strategies in the global orthopedics market. Contains ...

March 2017 30 pages

2017 Animal Health: Accelerated Rate of Change and Regulatory Uncertainty Confronting the Industry--Performance, Capabilities, Goals and Strategies of Leading Animal Health Companies

US$ 3,465.00

... of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such ... service and support. Customer relations. Internally developed and acquired animal health technologies, processes and related capabilities. Contains 110 pages and ...

March 2017 110 pages

2017 Chlamydia Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--USA, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

US$ 855.00

... supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chlamydia ... , in addition to test volume and sales projections, includes sales and market share estimates for major suppliers of Chlamydia tests.

March 2017 -

2017 Chancroid Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

US$ 540.00

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Chancroid tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public Health Labs

March 2017 -

2017 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Landscape

US$ 1,665.00

... opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... tasks for diagnostic companies during the next five years. France Market Overview Laboratories performing DNA sequencing and molecular ...

March 2017 407 pages

2017 Clinical Chemistry and Immunodiagnostics: A Market in Transition amid Regulatory Uncertainty and Intensifying Competition--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 22,050.00

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Antidepressants. Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison ...

March 2017 1115 pages

2017 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 17,730.00

... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ... of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business ...

March 2017 820 pages

2017 Future Horizons and Growth Strategies in the Global Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 31,950.00

... market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers by country. Test volume and sales forecasts ...

March 2017 800 pages

2017 France Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 6,030.00

... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ...

March 2017 585 pages

2017 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 6,030.00

... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany. Business ...

March 2017 585 pages

2017 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 7,920.00

... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ...

March 2017 590 pages

2017 Spain Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 6,030.00

... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ...

March 2017 565 pages

2017 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

US$ 6,030.00

... UK cancer diagnostics market during the nextfive years. The report examines trends in the UK market; reviews current and emerging assays; analyzes potential applications of new diagnostic ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...

March 2017 565 pages

2017 Future Horizons and Growth Strategies in the European Blood Banking Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US$ 17,730.00

... Spain- UKThe report explores future marketing and technological trends in Europe; provides estimates of the test volume, instrument placements and ... market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers by country. Test volume and sales forecasts ...

March 2017 600 pages

Filters

Search

Categories

3
6
249
2
165
164
52
726
612
487
422
365
289
206
808
227
226
183
47
33
17
17
15
14
10
8
7
5
4
3
2
2
2
1
1
2
5
1,360
40
576
38,287
43
8
15
2
1,289
1,108
237
1,201
134
97
1
69
3
53
631
6
932
21
6
1
253
3,934
324
1
644
585
228
219
202
93
69
35
17
15
812
27
333
85
11
1
1
550
20
108

Publishers

60,074

Regions

16
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
175
194
193
15
104
194
5
174
197
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
192
192
192
192
192
191
191
191
137
137
4
3
2
201
201
198
198
198
197
197
197
197
196
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
191
191
190
188
187
110
107
107
106
106
1,143
201
197
33,414
1,610
1,253
1,251
1,245
1,228
1,218
1,196
401
200

Price

Date

Pages

Offers